Further we clarified the roles and mechanisms of this designed EVs in osteolysis: miR-92a-1-5p enriched PCa EVs mediate osteoclast differentiation via MAPK1 and FoxO1, which may benefit the therapy of osteoblastic bone disease in the future. Here, MAPK1 is linked to posterior cortical atrophy.